Legend Biotech Corp. (LEGN)
28.12
+1.18
(+4.38%)
USD |
NASDAQ |
May 20, 16:00
27.68
-0.44
(-1.56%)
Pre-Market: 09:25
Legend Biotech EPS Diluted (Quarterly) : -0.2942 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Imunon, Inc. | -0.8449 |
| Capricor Therapeutics, Inc. | -0.591 |
| Viking Therapeutics, Inc. | -1.37 |
| Protagonist Therapeutics, Inc. | 0.0537 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.46M |
| Revenue (Quarterly) | 306.01M |
| Total Expenses (Quarterly) | 360.47M |
| Enterprise Value | 4.745B |
| Gross Profit Margin (Quarterly) | 37.23% |
| Profit Margin (Quarterly) | -17.80% |
| Earnings Yield | -4.84% |
| Normalized Earnings Yield | -4.798 |